Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effects. Webb AJ, Harper E, Rattay T, Aguado-Barrera ME, et al. Clin Cancer Res 2026 Jul 13. doi: 10.1158/1078-0432.CCR-26-0268.

Read + Share

Amedeo Smart

Independent Medical Education

Webb AJ, Harper E, Rattay T, Aguado-Barrera ME, et al. Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effects. Clin Cancer Res 2026 Jul 13. doi: 10.1158/1078-0432.CCR-26-0268.
PMID: 42440347